SCHEMBL26414756

SCHEMBL26414756

Bc1c(B)c(B)c(Cc2nc(-c3nc(C(F)(F)F)n[nH]3)cn3ccnc23)c(F)c1B

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26414862 0.84
SCHEMBL19922747 0.83 EPHB4 (0.30)
SCHEMBL19922748 0.81 PARP1 (0.33)
SCHEMBL19922749 0.80 EPHB4 (0.37)
SCHEMBL19922742 0.80 EPHB4 (0.35)
SCHEMBL30450190 0.80 EPHB4 (0.35)
SCHEMBL19922726 0.80 EPHB4 (0.32)
Zagociguat SCHEMBL19922804 0.79 AR (0.34)
SCHEMBL19922759 0.78 EPHB4 (0.32)
Zagociguat SCHEMBL21332996 0.78 AR (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230130739-A1 DEUTERATED sGC STIMULATORS TISENTO THERAPEUTICS INC. 2023-04-27 US disclosed